Wart therapies involve methods of targeted lesion destruction, as well as selective
immunologic modification. While there are several therapeutic options, no treatment has …

Background Several therapies have been proposed for cutaneous warts without results
concerning factors affecting recurrences. Objective To determine the importance of …

Immunotherapy has become one of the most important therapeutic tools for the treatment of
warts. At present, immunotherapy for warts is usually limited to recalcitrant lesions that are …

Plantar warts are among the most common skin conditions and are classically resistant to
treatment. To perform an evidence-based evaluation of the efficacy and safety of available …

Treatments for common and plantar warts | The BMJ Skip to main content Intended for
healthcare professionals Access provided by Google Indexer Subscribe My Account My email …

6.0 Background Warts are caused by infection of keratinocytes (the predominant cell type in
the epidermis) by human papillomavirus (HPV). The development of epidermal thickening …

Background Several general practitioner (GP)‐prescribed and over‐the‐counter therapies
for warts and verrucae are available. However, the cost‐effectiveness of these treatments is …

Cutaneous warts (verrucae) are benign, epithelial tumors characterized by the formation of
thick, hyperkeratotic lesions. Human papillomavirus (HPV) is a double-stranded DNA virus …

Extragenital cutaneous warts are benign epidermal tumors caused by human
papillomaviruses (HPVs) and a frequent reason for patients to consult a dermatologist …

Background Cutaneous warts have a cure rate after therapy of no more than approximately
50%. Recently, we developed and validated a standard assessment tool for warts …